NEWS

Using a closure analysis method to reduce CGT contamination risks

9 January 2022
Advanced Therapy Medicinal Products
Drug Substance
BioPhorum

Many cell therapy manufacturing processes use open unit manipulations. As a result, they are at risk of potential contamination that can result in manufacturing batch failure. The processes therefore rely on end-to-end aseptic processing to ensure the final drug product is safe and free of potentially harmful contamination.

Addressing these risks has led BioPhorum to publish Cell and gene therapy closed systems – closure analysis of a mock autologous cell therapy process. This documents a ‘mock’ process for manufacturing a generic autologous CAR-T product operated through a series of process steps combining open and closed system elements.

The paper demonstrates the systematic application of a closure analysis method on an ex vivo gene therapy process and has extensive appendices containing the process flow diagrams for each step. The closure analysis method used was based on BioPhorum’s Drug Substance Closed Systems Playbook.

Each appendix has a detailed closure analysis indicating the specific transfer input/output point marked on the diagram and an assessment of the ‘as-is’ condition. It also contains recommendations if a re-design is recommended, a suggested option for any re-design and an updated closure analysis of the suggested mitigation.

If readers do not have the time to work through each of the 12 appendices, there is a helpful overview map of the process flow diagrams, where each process box contains a hyperlink to the full diagrams in the appendices. This will help readers look at an appendix and just see the main issues and the options to solve them. Also, two appendices are summaries of the closure mitigations and closure analysis, enabling readers to see the mitigations and resultant impact on closure rating in a snapshot outside of the full manufacturing process.

The methodology will benefit other engineers when designing a process, such as those in gene therapy, by systematically evaluating each unit operation and classifying the level of closure. By taking this approach, engineers can design or improve a therapy manufacturing process and reduce the risk of contamination from open processes.

Technologies are being developed to provide a future state where cell therapy manufacturing processes will be scalable, automated, closed, and modified to fit nuanced or niche industry needs. However, with current technology limitations, a deliberate approach to process design is required to achieve an acceptable level of ‘closure’. Using the analysis in this BioPhorum paper means a controlled, closed, end-to-end cell therapy manufacturing process can be developed to produce a safe drug product with a low risk of process contamination.

NEWS
A unique safety data sheet for cell and gene therapies
Scenic Bridge
NEWS
Bridging the worlds of IT and CGT through analogies
Scientists Gene Therapy
NEWS
Guidance on minimizing the impact of stability studies on gene therapy batch yield
Germs On Green Background
NEWS
Building on industry feedback to standardize plasmid release specifications
Vials
NEWS
How to minimize the impact of CCIT on gene therapy batch yields

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing